📡 Signal Thesis
Quantum technology signal momentum is sharply accelerating, with 27 signals in the last 30 days representing nearly 59% of the trailing 90-day total—indicating a meaningful step-change in newsflow density around hardware milestones, error-correction progress, and enterprise pilot announcements. Pure-play names (IONQ, RGTI, QBTS) materially outpacing IBM's return suggests the market is repricing execution risk on near-term roadmap deliverables, though neutral article sentiment implies the narrative remains technically driven rather than euphoric. The trajectory points toward an inflection from research-st
📊 Signal Evidence
27
Signals last 30 days
46
Signals last 90 days
1.8x
Current vs 90-day avg rate
Neutral (+0.04)
Article sentiment
🏢 Top Companies & Domain Index
👁️
Showcase mode.
Company pages marked Premium will require a paid subscription when the platform launches. Full intelligence is visible now.
FSI Quantum Technology Index
▲ 43.8%
Average 90-day return across top 5 tracked companies
IONQ +76.3% · RGTI +37.0% · QBTS +49.7% · IBM +24.0% · QUBT +32.3%
| Ticker | Price | 30-Day Return | 90-Day Return |
|---|---|---|---|
| IONQ#1 | $72.07 | +71.1% | +76.3% |
| RGTI#2 | $25.54 | +58.8% | +37.0% |
| QBTS#3 Premium | $30.14 | +65.0% | +49.7% |
| IBM#4 Premium | $297.80 | +32.1% | +24.0% |
| QUBT#5 Premium | $11.96 | +44.4% | +32.3% |
Companies identified by FSI signal pipeline as operating in this domain. Not a recommendation to buy or sell.
🔬 Technology Intelligence Brief
Fundamental Research
Applied Research
Early Commercial
Scaling
Mature
Recent Breakthroughs
Recent months have seen credible logical qubit demonstrations, including Google's Willow chip showing below-threshold error correction and IBM's roadmap progress toward modular Heron and Kookaburra processors. IonQ and Quantinuum have pushed trapped-ion fidelities past 99.9% on multi-qubit gates, while neutral-atom players like Atom Computing and QuEra have demonstrated 256+ qubit arrays with mid-circuit measurement. Algorithmic advances in error mitigation and hybrid quantum-classical workflows are narrowing the gap to practical quantum advantage in chemistry and optimization.
12–24 Month Milestones to Watch
Watch for the first verifiable demonstrations of scientific quantum advantage on industrially relevant problems, expected from IBM, Google, or Quantinuum within 12-18 months. Key signposts include 100+ logical qubit systems, NIST PQC migration mandates driving cryptography refresh cycles, and DARPA's Quantum Benchmarking Initiative selecting finalists for utility-scale systems. Commercial milestones include multi-year enterprise contracts beyond pilots and the first quantum networking testbeds going live across metro distances.
🚀 Accelerators
A clearly demonstrated commercial quantum advantage in drug discovery, materials, or finance—validated by a non-quantum-vendor enterprise—would compress timelines significantly. Accelerated NIST post-quantum cryptography deadlines or a geopolitical 'Sputnik moment' triggering sovereign quantum funding waves could also pull demand forward.
⚠️ What Could Stall It
Persistent inability to scale logical qubits while maintaining fidelity, or a high-profile failure to reproduce claimed quantum advantage, could trigger a 'quantum winter' and valuation reset. Capital markets fatigue with pre-revenue pure-plays, combined with hyperscaler in-house programs absorbing demand, poses existential risk to smaller listed names.
Not investment advice. This scorecard is general signal intelligence derived from publicly available data. It does not constitute personalised investment advice or a recommendation to buy, sell, or hold any security. Past signal momentum does not guarantee future price performance. Capital at risk.